Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BiomX Inc. Director's Dealing 2021

Aug 17, 2021

35099_dirs_2021-08-17_1103c450-1537-4d30-9cdc-863f52de2ad0.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4/A — Form 4/A

Issuer: BiomX Inc. (PHGE)
CIK: 0001739174
Period of Report: 2021-07-26

Reporting Person: GROSSMAN JONAS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2021-07-26 Common Stock, par value $0.0001 P 37500 Acquired 372717 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-07-26 Warrants to purchase Common Stock $5.00 P 28125 Acquired 2027-01-28 Common Stock (28125) Direct

Footnotes

F1: The reporting person acquired 37,500 units consisting of one share of common stock and three-quarters of one warrant at a purchase price of $4.00 per unit.

F2: This number was originally reported as 372,217, as opposed to 372,717. This amendment is being filed to correct that typographical error.